Sanacorp Pharmahandel AG

euro adhoc: Sanacorp Pharmahandel AG
Justice/Processes
Appeal on points of law rejected in merger control proceedings

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

29.09.2006

By decision of today, September 29, 2006, the cartel division of the Higher Regional Court (Oberlandesgericht) in Düsseldorf dismissed the appeal of Sanacorp eG Pharmazeutische Großhandlung against the prohibition order issued by the Federal Cartel Authority with regard to the intended acquisition of the majority of shares in Andreae-Noris Zahn AG, Frankfurt am Main (ANZAG). The court denied an appeal on points of law against this decision.

Sanacorp eG Pharmazeutische Großhandlung is the parent company of Sanacorp Pharmahandel AG. It owns 100 % of the voting rights and some 75 % of the subscribed capital.

Sanacorp Pharmahandel Aktiengesellschaft is currently holding an interest of 24.99 % in ANZAG.

@@start.t2@@end of announcement                                                 euro adhoc 29.09.2006 12:25:29
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Sanacorp Pharmahandel AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Dr. Thomas Strieder
Tel.: +49 (0)89 8581 494
E-Mail: t.strieder@sanacorp.de

Branche: Wholesale
ISIN:      DE0007163131
WKN:        716313
Index:    CDAX, Classic All Share, Prime All Share
Börsen:  Frankfurter Wertpapierbörse / official dealing/prime standard
              Börse Berlin-Bremen / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Bayerische Börse / official dealing